Literature DB >> 15312792

Continuous exposure to brain-derived neurotrophic factor is required for persistent activation of TrkB receptor, the ERK signaling pathway, and the induction of neuropeptide Y production in cortical cultures.

Ayalla Barnea1, Jodie Roberts, Susan D Croll.   

Abstract

We have previously demonstrated that brain-derived neurotrophic factor (BDNF) induces persistent neuropeptide Y (NPY) production in cortical cultures in an ERK1/2-dependent manner. In some studies, it was shown that BDNF leads to the downregulation of TrkB receptor and some of its downstream responses, whereas in others it does not. We examined whether the BDNF requirement for induction of persistent NPY production correlates with that for induction of phosphorylation of TrkB and ERK1/2. Continuous 24-h exposure to BDNF led to a 2- to 3-fold increase in NPY production (maximal level). While 1 h of BDNF exposure induced NPY production at a half maximal level, 8 h was required for induction of a maximal level. BDNF-induced NPY production was completely inhibited by co-exposure to TrkB-Fc fusion protein (TrkB extracellular domain fused to Fc) and partially inhibited by TrkB-Fc added 1 h after BDNF; TrkC-Fc did not do so. Activation of TrkB receptor was analyzed at two potential tyrosine phosphorylated sites, the activation loop and the Shc binding. BDNF led to coordinated phosphorylation of the two sites that persisted for 6-8 h, and this was not associated with changes in the content of TrkB protein. The presence of BDNF throughout the 6- to 8-h period was required for the persistent phosphorylation of TrkB and ERK1/2. Thus, continuous BDNF activation of TrkB is required for persistent activation of the ERK1/2 pathway and induction of NPY production. We propose that, within the time frame analyzed in this study, BDNF does not lead to the downregulation of TrkB receptor or of the biological responses leading to NPY production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15312792     DOI: 10.1016/j.brainres.2004.06.018

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

Review 1.  Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Front Neuroendocrinol       Date:  2006-10-20       Impact factor: 8.606

2.  Knockdown of the transcript of ERK in the brain modulates hypothalamic neuropeptide-mediated appetite control in amphetamine-treated rats.

Authors:  Ching-Han Yu; Yih-Shou Hsieh; Pei-Ni Chen; Jeng-Rung Chen; Dong-Yih Kuo
Journal:  Br J Pharmacol       Date:  2018-01-11       Impact factor: 8.739

3.  Effects of single-dose neuropeptide Y on levels of hippocampal BDNF, MDA, GSH, and NO in a rat model of pentylenetetrazole-induced epileptic seizure.

Authors:  Hale Maral Kir; Deniz Sahin; Berrin Oztaş; Mert Musul; Sevinc Kuskay
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

4.  Molecular correlates of cortical network modulation by long-term sensory experience in the adult rat barrel cortex.

Authors:  Astrid Vallès; Ivica Granic; Peter De Weerd; Gerard J M Martens
Journal:  Learn Mem       Date:  2014-05-15       Impact factor: 2.460

5.  TrkB agonist antibody pretreatment enhances neuronal survival and long-term sensory motor function following hypoxic ischemic injury in neonatal rats.

Authors:  Gab Seok Kim; Seongeun Cho; James W Nelson; Gregory J Zipfel; Byung Hee Han
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

6.  Systems Biology of Immunomodulation for Post-Stroke Neuroplasticity: Multimodal Implications of Pharmacotherapy and Neurorehabilitation.

Authors:  Mohammed Aftab Alam; V P Subramanyam Rallabandi; Prasun K Roy
Journal:  Front Neurol       Date:  2016-06-28       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.